A new set of machine learning algorithms that can generate 3-D structures of tiny protein molecules may revolutionize the development of drug therapies for a range of diseases, from Alzheimer’s to cancer.
A new set of machine learning algorithms that can generate 3-D structures of tiny protein molecules may revolutionize the development of drug therapies for a range of diseases, from Alzheimer’s to cancer.